JPH0310565B2 - - Google Patents
Info
- Publication number
- JPH0310565B2 JPH0310565B2 JP6656282A JP6656282A JPH0310565B2 JP H0310565 B2 JPH0310565 B2 JP H0310565B2 JP 6656282 A JP6656282 A JP 6656282A JP 6656282 A JP6656282 A JP 6656282A JP H0310565 B2 JPH0310565 B2 JP H0310565B2
- Authority
- JP
- Japan
- Prior art keywords
- solution
- sodium
- sodium hexametaphosphate
- preparation
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 claims description 28
- 235000019982 sodium hexametaphosphate Nutrition 0.000 claims description 28
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 26
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 10
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 10
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 7
- 239000011736 potassium bicarbonate Substances 0.000 claims description 6
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 6
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 6
- 239000000243 solution Substances 0.000 description 25
- 238000002360 preparation method Methods 0.000 description 16
- 239000012153 distilled water Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 208000001130 gallstones Diseases 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 201000001883 cholelithiasis Diseases 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000019830 sodium polyphosphate Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 210000003228 intrahepatic bile duct Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical class OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6656282A JPS58185413A (ja) | 1982-04-20 | 1982-04-20 | 新規なヘキサメタリン酸ナトリウム溶液の調製法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6656282A JPS58185413A (ja) | 1982-04-20 | 1982-04-20 | 新規なヘキサメタリン酸ナトリウム溶液の調製法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58185413A JPS58185413A (ja) | 1983-10-29 |
| JPH0310565B2 true JPH0310565B2 (enrdf_load_stackoverflow) | 1991-02-14 |
Family
ID=13319500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6656282A Granted JPS58185413A (ja) | 1982-04-20 | 1982-04-20 | 新規なヘキサメタリン酸ナトリウム溶液の調製法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58185413A (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4824649A (en) * | 1987-08-31 | 1989-04-25 | Stauffer Chemical Company | High viscosity potassium metaphosphate |
| CN101811683B (zh) * | 2010-04-15 | 2012-08-08 | 邹召贵 | 热法磷酸装置余热生产磷酸盐的方法 |
-
1982
- 1982-04-20 JP JP6656282A patent/JPS58185413A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58185413A (ja) | 1983-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3619921B2 (ja) | 重炭酸固形透析用剤 | |
| DE60030682T2 (de) | Zweiteilige bicarbonatlösung für die peritonealdialyse oder als substitutionslösung für die kontinuierliche nierensubstitutionstherapie | |
| PL96082B1 (pl) | Sposob wytwarzania nowych bis-/dwuhydroksypropyloamidow/kwasu 5-hydroksypropionyloamino-2,4,6-trojjodoizoftalowego | |
| US3560380A (en) | Dry concentrates for preparing hemodialysis solutions | |
| EP0055029B1 (en) | Preparations for the treatment of dermatoses | |
| PT99914A (pt) | Processo para a preparacao de composicoes estabilizadoras dentarias com adesividade melhorada que compreendem sais parciais mistos de um copolimero do acido alquil-vinil-eter-maleico inferior | |
| WO2018079022A1 (ja) | 血液透析用ａ剤 | |
| NO148803B (no) | Radioaktivt preparat til scintigrafisk gjengivelse av det hepatobiliaere system som inneholder et kompleks av ved reduksjon av et perteknetat dannede 99m teknetiumioner med dikarboksylsyre av acetanilidoiminodieddiksyre-rekken | |
| ATE6645T1 (de) | Dibenzoxazepin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| Rosenthal et al. | Compounds Related to α-Glycerophosphoric Acid, Phosphorylcholine and Phosphorylethanolamine1 | |
| CA1281650C (en) | Aqueous preparation containing cyclodextrin | |
| JPH0310565B2 (enrdf_load_stackoverflow) | ||
| HK101192A (en) | Dry substances and stable suspensions | |
| EP4027977A1 (en) | Pharmaceutical composition of bimatoprost and timolol | |
| CN101400262A (zh) | 新植酸柠檬酸化合物及其制备方法 | |
| JP3947995B2 (ja) | 重炭酸固形透析用剤 | |
| JPS6245524A (ja) | ナトリウムフエニトイン水性製剤 | |
| US1983954A (en) | Medicine and process of preparing same | |
| JP2986256B2 (ja) | 血液透析用顆粒剤 | |
| US3347746A (en) | Injectable solution of an amine salt of a radiopaque iodinated organic acid containing calcium ions | |
| JPH01290619A (ja) | 口腔用組成物の製造法 | |
| JP3003504B2 (ja) | 電解質輸液剤 | |
| RU2238735C1 (ru) | Средство для литолиза мочевых камней и способ его получения | |
| JPS6160608A (ja) | ジクロフェナック湿布剤 | |
| US2336022A (en) | X-ray contrast composition |